These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36779015)

  • 21. Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy.
    Gomez-Murcia V; Sandau U; Ferry B; Parrot S; Laurent C; Basquin M; Buée L; Boison D; Blum D
    Neurobiol Aging; 2020 Oct; 94():265-270. PubMed ID: 32679397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice.
    Martel G; Simon A; Nocera S; Kalainathan S; Pidoux L; Blum D; Leclère-Turbant S; Diaz J; Geny D; Moyse E; Videau C; Buée L; Epelbaum J; Viollet C
    Neurobiol Aging; 2015 Feb; 36(2):1013-28. PubMed ID: 25433460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.
    Leboucher A; Ahmed T; Caron E; Tailleux A; Raison S; Joly-Amado A; Marciniak E; Carvalho K; Hamdane M; Bantubungi K; Lancel S; Eddarkaoui S; Caillierez R; Vallez E; Staels B; Vieau D; Balschun D; Buee L; Blum D
    Neurobiol Dis; 2019 May; 125():14-22. PubMed ID: 30665005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
    Han P; Dou F; Li F; Zhang X; Zhang YW; Zheng H; Lipton SA; Xu H; Liao FF
    J Neurosci; 2005 Dec; 25(50):11542-52. PubMed ID: 16354912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
    Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
    Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
    Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
    Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy.
    Delay-Goyet P; Blanchard V; Schussler N; Lopez-Grancha M; Ménager J; Mary V; Sultan E; Buzy A; Guillemot JC; Stemmelin J; Bertrand P; Rooney T; Pradier L; Barnéoud P
    Alzheimers Dement (N Y); 2016 Nov; 2(4):267-280. PubMed ID: 29067314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
    Tanaka T; Ohashi S; Takashima A; Kobayashi S
    Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of NR4A1 on APP metabolism and tau phosphorylation.
    Zhao LG; Tang Y; Tan JZ; Wang JW; Chen GJ; Zhu BL
    Genes Dis; 2018 Dec; 5(4):342-348. PubMed ID: 30591936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
    Huber CM; Yee C; May T; Dhanala A; Mitchell CS
    J Alzheimers Dis; 2018; 61(1):265-281. PubMed ID: 29154274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.
    Zhao H; Chang R; Che H; Wang J; Yang L; Fang W; Xia Y; Li N; Ma Q; Wang X
    Neurosci Lett; 2013 Sep; 551():12-6. PubMed ID: 23810804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
    Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
    J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological and pathological phosphorylation of tau by Cdk5.
    Kimura T; Ishiguro K; Hisanaga S
    Front Mol Neurosci; 2014; 7():65. PubMed ID: 25076872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
    Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
    Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
    García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
    J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts.
    Hernandez P; Lee G; Sjoberg M; Maccioni RB
    J Alzheimers Dis; 2009; 16(1):149-56. PubMed ID: 19158430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
    Sanchez-Mejias E; Navarro V; Jimenez S; Sanchez-Mico M; Sanchez-Varo R; Nuñez-Diaz C; Trujillo-Estrada L; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    Acta Neuropathol; 2016 Dec; 132(6):897-916. PubMed ID: 27743026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.